ภาษาไทย
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#cholangiocarcinoma ผลการค้นหา

HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
4 พ.ย.

🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
0
5
24
7
2พัน
BeauToskichMD's profile picture. Professor of Radiology, Director of Interventional Oncology, Mayo Clinic Florida. Views are my own.
Beau Bosko Toskich, MD FSIR
@BeauToskichMD
24 ต.ค.

Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…

BeauToskichMD's tweet image. Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…
BeauToskichMD's tweet image. Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…
BeauToskichMD's tweet image. Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…
FlavioRochaMD's profile picture. Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute 🇺🇸 🇧🇷 in #PDX #PNW 🏔️ 🌲 🌊 ASCO FCOI: https://t.co/8W15jPkVs7
Flavio G Rocha, MD, FACS, FSSO
 @FlavioRochaMD
24 ต.ค.

Real world 🌎 #NEOGAP #cholangiocarcinoma @OHSUKnight @curecc @c3_cholangio 💚

0
3
16
1
5พัน
1
6
50
5
4พัน
BasGrootKoerkam's profile picture. HPB-transplant surgeon
Bas Groot Koerkamp
 @BasGrootKoerkam
3 ต.ค.

Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage authors.elsevier.com/sd/article/S25…

BasGrootKoerkam's tweet image. Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage authors.elsevier.com/sd/article/S25…
1
16
42
11
4พัน
staclinds's profile picture. CEO and Founder of the Cholangiocarcinoma Foundation, mother of 5, happily married.
Stacie Lindsey
 @staclinds
6 พ.ย.

This #NationalFamilyCaregiversMonth, we honor those walking beside loved ones with cholangiocarcinoma—offering comfort, learning, and spreading hope. 💚 Watch Cynthia’s heartfelt tribute to the caregivers who make this journey possible. 🎥 #Cholangiocarcinoma #Caregivers

0
0
2
0
60
CharityAMMF's profile picture. AMMF is the UK's only cholangiocarcinoma (bile duct cancer) charity. Working throughout the UK and Europe, and collaborating globally.
AMMF
 @CharityAMMF
31 ต.ค.

Yesterday, the Scottish Parliament debated #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can read a summary of the debate and watch the recording on the AMMF website: ammf.org.uk/2025/10/31/sco…

CharityAMMF's tweet image. Yesterday, the Scottish Parliament debated #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can read a summary of the debate and watch the recording on the AMMF website: ammf.org.uk/2025/10/31/sco…
0
2
6
0
97
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
31 ต.ค.

🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
0
2
4
1
914
HPBEverestMD's profile picture. General/GI Surgery.MCh 🩺 Executive Member of Society of Surgeons of Nepal (2025-2027)🇳🇵
Uttam Laudari
 @HPBEverestMD
30 ต.ค.

💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery

HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
0
6
7
0
6พัน
DeCarlis_R's profile picture. 🇮🇹 HPB & Transplant Surgeon (liver/kidney/pancreas). Laparoscopy & robot. DCD & machine perfusion. Fond of my job. Tweets are my own.
Riccardo De Carlis
 @DeCarlis_R
6 ส.ค.

Right hemi-hepatectomy plus total caudate lobectomy for perihilar #cholangiocarcinoma

DeCarlis_R's tweet image. Right hemi-hepatectomy plus total caudate lobectomy for perihilar #cholangiocarcinoma
1
1
24
2
1พัน
KeckMedicineUSC's profile picture. The University of Southern California’s medical enterprise, Keck Medicine of USC is renowned for world-class health care and research. #KeckMedicine
Keck Medicine of USC
@KeckMedicineUSC
8 ส.ค.

📽️ Ever heard of #cholangiocarcinoma? It’s a rare cancer that affects the bile ducts — and knowing the basics could make a big difference. Learn about the symptoms to look out for.

0
3
2
1
2พัน
HelenMorement's profile picture. Helen Morement, DSc (hc), CEO of @CharityAMMF. At the heart of AMMF is #OurCCAFamily – every person diagnosed with #cholangiocarcinoma and their loved ones.
Helen Morement
 @HelenMorement
6 พ.ค.

All set and ready this evening to welcome everyone to #AMMF's European #Cholangiocarcinoma Conference starting tomorrow. Looking forward to the next 3 days!! #AMMF2025

HelenMorement's tweet image. All set and ready this evening to welcome everyone to #AMMF's European #Cholangiocarcinoma Conference starting tomorrow. Looking forward to the next 3 days!! #AMMF2025
0
4
20
1
421
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
3 พ.ย.

🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy

HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
0
1
2
1
654
malkadav's profile picture. GI oncologist, MD, PhD (FRA)
David Malka
 @malkadav
10 เม.ย.

Interested in precision medicine and #BTC #cholangiocarcinoma? Read our paper @ESMO_Open! authors.elsevier.com/sd/article/S20…

malkadav's tweet image. Interested in precision medicine and #BTC #cholangiocarcinoma? Read our paper @ESMO_Open! authors.elsevier.com/sd/article/S20…
2
19
54
18
6พัน
MathurAmitK's profile picture. Transplant/HB Surgeon/Professor @MayoClinic | Interests: Transplant Practice, Research, Quality, Policy, Education | @nldac_asts | @UF @UMichSurgery Alum
Amit K. Mathur, MD MS FACS
@MathurAmitK
14 ธ.ค.

Getting ready to start some Saturday learning with INEDSYS Hepatology club on LT and #cholangiocarcinoma @inedsys …great stuff on YouTube as well. The global perspective is pretty impressive!

MathurAmitK's tweet image. Getting ready to start some Saturday learning with INEDSYS Hepatology club on LT and #cholangiocarcinoma @inedsys …great stuff on YouTube as well. The global perspective is pretty impressive!
3
0
26
0
904
boulter_lab's profile picture. Cancer Research UK funded group @MRC_HGU: liver cancer, signalling, lifting, ductular development and repair, gene editing and diversity in STEM.
Liver Growth and Cancer Lab
 @boulter_lab
17 เม.ย. 2024

Starting the inaugural basic science track @curecc a real pleasure to be part of this exciting group of researchers. #cholangiocarcinoma

boulter_lab's tweet image. Starting the inaugural basic science track @curecc a real pleasure to be part of this exciting group of researchers. #cholangiocarcinoma
0
6
22
1
1พัน
MarioBalsaMD's profile picture. Medical Oncology resident at @ICO_oncologia | Currently Rotation Resident Research at @MDAndersonNews 🇺🇸 | @OncoAlert team 💥 #OncoAlertAF | Pianist 🎹
Mario Balsa
@MarioBalsaMD
20 ต.ค.

🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…

MarioBalsaMD's tweet image. 🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…
MarioBalsaMD's tweet image. 🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…
MarioBalsaMD's tweet image. 🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…
0
15
32
10
2พัน
curecc's profile picture. Our mission is to find a cure and improve the quality of life for cholangiocarcinoma patients. #CCAhope
Cholangiocarcinoma Foundation
@curecc
5 ก.ค.

A CCA survivor thriver, his wife & his oncologist, Dr. Katie Kelley, just climbed to the top of Salesforce Tower 💪 She’s a CCF Innovation Grant recipient & Mark R. Clements Awardee—and a true partner in the climb toward a cure. #Cholangiocarcinoma #LivingBeyondDiagnosis…

curecc's tweet image. A CCA survivor thriver, his wife & his oncologist, Dr. Katie Kelley, just climbed to the top of Salesforce Tower 💪 She’s a CCF Innovation Grant recipient & Mark R. Clements Awardee—and a true partner in the climb toward a cure. #Cholangiocarcinoma #LivingBeyondDiagnosis…
0
2
19
0
542
HelenMorement's profile picture. Helen Morement, DSc (hc), CEO of @CharityAMMF. At the heart of AMMF is #OurCCAFamily – every person diagnosed with #cholangiocarcinoma and their loved ones.
Helen Morement
 @HelenMorement
26 ก.พ.

Today's the day! #AMMF is heading to Westminster to ask for a #FairerDealFaster for all with #cholangiocarcinoma! @charityammf

HelenMorement's tweet image. Today's the day! #AMMF is heading to Westminster to ask for a #FairerDealFaster for all with #cholangiocarcinoma! @charityammf
1
6
17
0
480
staclinds's profile picture. CEO and Founder of the Cholangiocarcinoma Foundation, mother of 5, happily married.
Stacie Lindsey
 @staclinds
6 พ.ย.

This #NationalFamilyCaregiversMonth, we honor those walking beside loved ones with cholangiocarcinoma—offering comfort, learning, and spreading hope. 💚 Watch Cynthia’s heartfelt tribute to the caregivers who make this journey possible. 🎥 #Cholangiocarcinoma #Caregivers

0
0
2
0
60
CharityAMMF's profile picture. AMMF is the UK's only cholangiocarcinoma (bile duct cancer) charity. Working throughout the UK and Europe, and collaborating globally.
AMMF
 @CharityAMMF
6 พ.ย.

💜SAVE THE DATE – REGISTRATION OPENING SOON💜 #AMMF’s 2026 European #Cholangiocarcinoma Conference: 📅 13–15 May 2026 at the 📍Radisson Blu Hotel, Stansted, UK Stay tuned, registration will be launching soon! #bileductcancer #AMMFConference2026 #CCA

CharityAMMF's tweet image. 💜SAVE THE DATE – REGISTRATION OPENING SOON💜 #AMMF’s 2026 European #Cholangiocarcinoma Conference: 📅 13–15 May 2026 at the 📍Radisson Blu Hotel, Stansted, UK Stay tuned, registration will be launching soon! #bileductcancer #AMMFConference2026 #CCA
0
1
1
0
73
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
5 พ.ย.

👏 This paper uncovers how altered #glucose metabolism fuels #cholangiocarcinoma growth and explores metabolic vulnerabilities as promising therapeutic targets. From: Dr. Charupong Saengboonmee @ASingkarin @DrSabha @DrTravisBrown @PaulJBrindley @Chillslincoln79 @DanielJDrucker

HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
5 พ.ย.

🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer

HepatomaRes's tweet image. 🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer
HepatomaRes's tweet image. 🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer
HepatomaRes's tweet image. 🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer
HepatomaRes's tweet image. 🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer
0
0
1
0
322
0
0
1
0
187
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
5 พ.ย.

🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer

HepatomaRes's tweet image. 🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer
HepatomaRes's tweet image. 🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer
HepatomaRes's tweet image. 🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer
HepatomaRes's tweet image. 🍬 Glucose Addiction in #Cholangiocarcinoma: Opportunities for Therapeutic Development 🔥 Metabolic reprogramming driving CCA progression 🔥 Targeting glucose dependency for treatment 🔥 Translational insights for metabolic therapy 🔗 [oaepublish.com/articles/2394-…] #BileDuctCancer
0
0
1
0
322
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
4 พ.ย.

🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
0
5
24
7
2พัน
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
3 พ.ย.

🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy

HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
0
1
2
1
654
FlavioRochaMD's profile picture. Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute 🇺🇸 🇧🇷 in #PDX #PNW 🏔️ 🌲 🌊 ASCO FCOI: https://t.co/8W15jPkVs7
Flavio G Rocha, MD, FACS, FSSO
 @FlavioRochaMD
1 พ.ย.

Please consider applying to this great program if interested in #cholangiocarcinoma globally 🌎 #mentorship #payitforward #nextgeneration

staclinds's profile picture. CEO and Founder of the Cholangiocarcinoma Foundation, mother of 5, happily married.
Stacie Lindsey
 @staclinds
31 ต.ค.

📢 Deadline Extension: The Precision-BTC-Network, in collaboration with ENS-CCA and @curecc's International Cholangiocarcinoma Research Network, invites applications for its Mentorship Program. NEW application deadline: November 7 🌐lnkd.in/d6aFK_DA

0
1
4
0
3พัน
0
0
9
1
2พัน
Springer_Med's profile picture. Trustworthy, tailored, cutting-edge content for medical professionals who want to deliver the best possible care. #EdsChoice selections by the content team.
Springer Medicine
 @Springer_Med
1 พ.ย.

Unfortunately only 15–25% of patients with #cholangiocarcinoma qualify for second-line therapy. But what are the current treatment options for these patients, what therapies are on the horizon, and can biomarkers help to improve outcomes? 👉 buff.ly/Ow5YL6A #OncTwitter

0
0
0
0
76
VautheyMD's profile picture.
Jean-Nicolas Vauthey MD
 @VautheyMD
31 ต.ค.

Important feature #intrahepatic #cholangiocarcinoma = desmoplastic reaction. May extend beyond the tumor in portal triads, hepatic hilum and extrahepatically along hepatic veins. Increased duration and difficulty of surgery!👇 #oncsurgery @SSATNews @AHPBA @IHPBA

HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
27 ต.ค.

👏 This paper investigates the diverse roles of collagen molecules in #intrahepatic #cholangiocarcinoma, revealing their impact on tumor growth, invasion, and remodeling of the extracellular matrix. @DrNguyenhiep @timnewhook19 @HalletJulie @FlavioRochaMD @skmaithel @VautheyMD

0
1
9
3
2พัน
0
3
14
3
1พัน
CharityAMMF's profile picture. AMMF is the UK's only cholangiocarcinoma (bile duct cancer) charity. Working throughout the UK and Europe, and collaborating globally.
AMMF
 @CharityAMMF
31 ต.ค.

Yesterday, the Scottish Parliament debated #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can read a summary of the debate and watch the recording on the AMMF website: ammf.org.uk/2025/10/31/sco…

CharityAMMF's tweet image. Yesterday, the Scottish Parliament debated #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can read a summary of the debate and watch the recording on the AMMF website: ammf.org.uk/2025/10/31/sco…
0
2
6
0
97
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
31 ต.ค.

🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
0
2
4
1
914
CharityAMMF's profile picture. AMMF is the UK's only cholangiocarcinoma (bile duct cancer) charity. Working throughout the UK and Europe, and collaborating globally.
AMMF
 @CharityAMMF
30 ต.ค.

At 5pm today, the Scottish Parliament will debate #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can watch the debate live online, or as an on-demand recording. 🔗 Watch now | scottishparliament.tv #RethinkLiverCancer #Scotland #debate

CharityAMMF's tweet image. At 5pm today, the Scottish Parliament will debate #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can watch the debate live online, or as an on-demand recording. 🔗 Watch now | scottishparliament.tv #RethinkLiverCancer #Scotland #debate
0
1
2
0
74
CurrentOncology's profile picture. Current Oncology (ISSN: 1718-7729, IF 3.4) is an international, scientific, peer reviewed, #openaccess journal published monthly by @MDPIopenaccess. #oncology
Current Oncology
 @CurrentOncology
30 ต.ค.

📅 New #Review in #Vol32_Iss10 📑 "Neoadjuvant Strategies for Patients with Resectable Biliary Tract Cancers: A Review" ✍️ by Chelsea R. Olson et al. 📍 Access the full paper here: brnw.ch/21wX3yc #Cholangiocarcinoma #NeoadjuvantTherapy

0
0
0
0
36
HPBEverestMD's profile picture. General/GI Surgery.MCh 🩺 Executive Member of Society of Surgeons of Nepal (2025-2027)🇳🇵
Uttam Laudari
 @HPBEverestMD
30 ต.ค.

💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery

HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
0
6
7
0
6พัน
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
30 ต.ค.

👏 This narrative review summarizes recent progress in liver #transplantation for #intrahepatic #cholangiocarcinoma, highlighting refined selection criteria, improved outcomes, and future directions in patient management. @CalderonNo81257 @frandesanti @TorzilliGuido @pashtoonkasi

HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
30 ต.ค.

🩹 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Latest Advances and Evolving Perspectives 🧬Refined transplant selection & outcomes 🧬 Integration of systemic and locoregional therapies 🧬 Redefining transplantation in iCCA management 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🩹 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Latest Advances and Evolving Perspectives 🧬Refined transplant selection & outcomes 🧬 Integration of systemic and locoregional therapies 🧬 Redefining transplantation in iCCA management 🔗 [oaepublish.com/articles/2394-…]
0
0
3
0
338
0
1
3
0
237
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
30 ต.ค.

🩹 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Latest Advances and Evolving Perspectives 🧬Refined transplant selection & outcomes 🧬 Integration of systemic and locoregional therapies 🧬 Redefining transplantation in iCCA management 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🩹 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Latest Advances and Evolving Perspectives 🧬Refined transplant selection & outcomes 🧬 Integration of systemic and locoregional therapies 🧬 Redefining transplantation in iCCA management 🔗 [oaepublish.com/articles/2394-…]
0
0
3
0
338
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
30 ต.ค.

🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]
0
1
3
0
553
GiOncNow's profile picture. GI Oncology Now brings you the latest research and updates in #livercancer, #coloncancer, #pancreaticcancer, and more in the gastrointestinal oncology sphere.
GI Oncology Now
 @GiOncNow
29 ต.ค.

📺 Dr. Matthew Krebs of @OfficialUoM describes the rationale behind his study presented at #ESMO25 that explored the next-generation KRAS G12C inhibitor #divarasib in pancreatic cancer and #cholangiocarcinoma: buff.ly/bLYl8HE

0
0
0
0
90
BasGrootKoerkam's profile picture. HPB-transplant surgeon
Bas Groot Koerkamp
 @BasGrootKoerkam
3 ต.ค.

Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage authors.elsevier.com/sd/article/S25…

BasGrootKoerkam's tweet image. Primary percutaneous stenting for malignant hilar biliary obstruction. No longer cholangitis or pancreatitis keeping you from systemic treatment. #cholangiocarcinoma #drainage authors.elsevier.com/sd/article/S25…
1
16
42
11
4พัน
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
4 พ.ย.

🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Liver Transplantation for Intrahepatic #Cholangiocarcinoma: Insights from the UK NHSBT Pilot Programme 🇬🇧 Evidence from a national pilot initiative 📊 Refined selection & transplant outcomes 💡 Expanding treatment frontiers in iCCA care 🔗 [oaepublish.com/articles/2394-…]
0
5
24
7
2พัน
BeauToskichMD's profile picture. Professor of Radiology, Director of Interventional Oncology, Mayo Clinic Florida. Views are my own.
Beau Bosko Toskich, MD FSIR
@BeauToskichMD
24 ต.ค.

Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…

BeauToskichMD's tweet image. Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…
BeauToskichMD's tweet image. Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…
BeauToskichMD's tweet image. Unresectable intrahepatic #cholangiocarcinoma conversion/transplantation is our #1 MDT mission. 🤝 This evidence is so welcome. ✨ Inadequate FLR, tumor response, and biological test-of-time are addressed with neoadjuvant #Y90 radiation lobectomy. 🌳 We are exploring this…
FlavioRochaMD's profile picture. Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute 🇺🇸 🇧🇷 in #PDX #PNW 🏔️ 🌲 🌊 ASCO FCOI: https://t.co/8W15jPkVs7
Flavio G Rocha, MD, FACS, FSSO
 @FlavioRochaMD
24 ต.ค.

Real world 🌎 #NEOGAP #cholangiocarcinoma @OHSUKnight @curecc @c3_cholangio 💚

0
3
16
1
5พัน
1
6
50
5
4พัน
curecc's profile picture. Our mission is to find a cure and improve the quality of life for cholangiocarcinoma patients. #CCAhope
Cholangiocarcinoma Foundation
@curecc
3 ต.ค.

Kicking off the 7th Annual #Cholangiocarcinoma Summit in Scottsdale, AZ. 🌵 Together, we’re building knowledge, community, and hope.

curecc's tweet image. Kicking off the 7th Annual #Cholangiocarcinoma Summit in Scottsdale, AZ. 🌵 Together, we’re building knowledge, community, and hope.
curecc's tweet image. Kicking off the 7th Annual #Cholangiocarcinoma Summit in Scottsdale, AZ. 🌵 Together, we’re building knowledge, community, and hope.
curecc's tweet image. Kicking off the 7th Annual #Cholangiocarcinoma Summit in Scottsdale, AZ. 🌵 Together, we’re building knowledge, community, and hope.
curecc's tweet image. Kicking off the 7th Annual #Cholangiocarcinoma Summit in Scottsdale, AZ. 🌵 Together, we’re building knowledge, community, and hope.
0
7
26
0
3พัน
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
3 พ.ย.

🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy

HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
HepatomaRes's tweet image. 🎯 Challenges and Opportunities in Treating Intrahepatic #Cholangiocarcinoma: Targeted Therapy Perspectives 🧬 Precision oncology in #iCCA 🔍 Targeting driver mutations & pathways 💡 Expanding options for individualized care 🔗 [oaepublish.com/articles/2394-…] #TargetedTherapy
0
1
2
1
654
MarioBalsaMD's profile picture. Medical Oncology resident at @ICO_oncologia | Currently Rotation Resident Research at @MDAndersonNews 🇺🇸 | @OncoAlert team 💥 #OncoAlertAF | Pianist 🎹
Mario Balsa
@MarioBalsaMD
20 ต.ค.

🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…

MarioBalsaMD's tweet image. 🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…
MarioBalsaMD's tweet image. 🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…
MarioBalsaMD's tweet image. 🚨#ESMO25 #Cholangiocarcinoma –Phase 2–3 ZSAB-neoGOLP trial (Toripalimab + Lenvatinib + GEMOX) in resectable high-risk iCCA 🎯 mEFS 18.0 vs 8.7 mo 💥 ORR 54.4% | MPR 19.3% | pCR 4.5% ✨ OS trend favoring neoadjuvant arm (NE vs 31.4 mo) A strong neoadjuvant signal! Sometimes the…
0
15
32
10
2พัน
Youssefmd96's profile picture. 🌱 IM PGY-2, ex-researcher future Gastroenterologist
Mohammed Youssef MD,
 @Youssefmd96
19 เม.ย. 2024

Glad to share that have I presented two abstracts at the CCF Conference! @curecc Thanks Dr. @LewisRobertsMD for the guidance and support. #CCFConference #cholangiocarcinoma

Youssefmd96's tweet image. Glad to share that have I presented two abstracts at the CCF Conference! @curecc Thanks Dr. @LewisRobertsMD for the guidance and support. #CCFConference #cholangiocarcinoma
Youssefmd96's tweet image. Glad to share that have I presented two abstracts at the CCF Conference! @curecc Thanks Dr. @LewisRobertsMD for the guidance and support. #CCFConference #cholangiocarcinoma
Youssefmd96's tweet image. Glad to share that have I presented two abstracts at the CCF Conference! @curecc Thanks Dr. @LewisRobertsMD for the guidance and support. #CCFConference #cholangiocarcinoma
2
5
60
3
6พัน
malkadav's profile picture. GI oncologist, MD, PhD (FRA)
David Malka
 @malkadav
10 เม.ย.

Interested in precision medicine and #BTC #cholangiocarcinoma? Read our paper @ESMO_Open! authors.elsevier.com/sd/article/S20…

malkadav's tweet image. Interested in precision medicine and #BTC #cholangiocarcinoma? Read our paper @ESMO_Open! authors.elsevier.com/sd/article/S20…
2
19
54
18
6พัน
HPBEverestMD's profile picture. General/GI Surgery.MCh 🩺 Executive Member of Society of Surgeons of Nepal (2025-2027)🇳🇵
Uttam Laudari
 @HPBEverestMD
30 ต.ค.

💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery

HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
HPBEverestMD's tweet image. 💡 Takeaway: Integration of AI, molecular profiling & precision surgery is redefining ICC outcomes. 🌍 #APHPBA #HPBSurgery #Cholangiocarcinoma #SurgicalOncology #AIinSurgery
0
6
7
0
6พัน
FlavioRochaMD's profile picture. Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute 🇺🇸 🇧🇷 in #PDX #PNW 🏔️ 🌲 🌊 ASCO FCOI: https://t.co/8W15jPkVs7
Flavio G Rocha, MD, FACS, FSSO
 @FlavioRochaMD
13 ต.ค.

Phenomenal 🤩 Surgery Grand Rounds this am by Visiting Professor @Majeldoyle @WashU on rapidly evolving role of #transplantoncology for cancer #HCC #cholangiocarcinoma #CRLM 🔑 takeaways: 1) Patient selection 🧬 2) Treatment sequence/#HAI ⛽️ 3) Organ availability/allocation

FlavioRochaMD's tweet image. Phenomenal 🤩 Surgery Grand Rounds this am by Visiting Professor @Majeldoyle @WashU on rapidly evolving role of #transplantoncology for cancer #HCC #cholangiocarcinoma #CRLM 🔑 takeaways: 1) Patient selection 🧬 2) Treatment sequence/#HAI ⛽️ 3) Organ availability/allocation
FlavioRochaMD's tweet image. Phenomenal 🤩 Surgery Grand Rounds this am by Visiting Professor @Majeldoyle @WashU on rapidly evolving role of #transplantoncology for cancer #HCC #cholangiocarcinoma #CRLM 🔑 takeaways: 1) Patient selection 🧬 2) Treatment sequence/#HAI ⛽️ 3) Organ availability/allocation
FlavioRochaMD's tweet image. Phenomenal 🤩 Surgery Grand Rounds this am by Visiting Professor @Majeldoyle @WashU on rapidly evolving role of #transplantoncology for cancer #HCC #cholangiocarcinoma #CRLM 🔑 takeaways: 1) Patient selection 🧬 2) Treatment sequence/#HAI ⛽️ 3) Organ availability/allocation
0
2
22
0
1พัน
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
31 ต.ค.

🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🔪 Surgery for #HepatocellularCarcinoma and Intrahepatic #Cholangiocarcinoma: Two Decades of Milestone Changes 🏥 Evolution of surgical strategies 📊 Impact on prognosis and clinical practice 💡 Insights guiding future guideline updates 🔗 [oaepublish.com/articles/2394-…]
0
2
4
1
914
HepatomaRes's profile picture. A gold open-access journal, indexed in ESCI and Scopus, 2023 IF: 1.7. #livercancer #HCC #CCA #Hepatitis #liverdisease #livertwitter #MedEd #HCCtwitter
Hepatoma Research
 @HepatomaRes
30 ต.ค.

🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]

HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]
HepatomaRes's tweet image. 🩺 Neoadjuvant Chemotherapy ± Trans-Arterial Therapies for Downstaging Unresectable Intrahepatic #Cholangiocarcinoma 💡 #Multimodal downstaging strategies 💡 Expanding surgical eligibility in #iCCA 💡 Toward better prognosis through tailored therapy 🔗 [oaepublish.com/articles/2394-…]
0
1
3
0
553
Penn_IR's profile picture. #minimallyinvasive
PennIR
 @Penn_IR
5 มี.ค. 2023

Next up is @TerenceGade talking about biomarkers for #HCC and #Cholangiocarcinoma #SIR23PHX

Penn_IR's tweet image. Next up is @TerenceGade talking about biomarkers for #HCC and #Cholangiocarcinoma #SIR23PHX
0
4
18
0
2พัน
CharityAMMF's profile picture. AMMF is the UK's only cholangiocarcinoma (bile duct cancer) charity. Working throughout the UK and Europe, and collaborating globally.
AMMF
 @CharityAMMF
31 ต.ค.

Yesterday, the Scottish Parliament debated #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can read a summary of the debate and watch the recording on the AMMF website: ammf.org.uk/2025/10/31/sco…

CharityAMMF's tweet image. Yesterday, the Scottish Parliament debated #cholangiocarcinoma awareness for #LiverCancerAwarenessMonth. You can read a summary of the debate and watch the recording on the AMMF website: ammf.org.uk/2025/10/31/sco…
0
2
6
0
97
FlavioRochaMD's profile picture. Hedinger Chair of Surgical Oncology and Physician-in-Chief OHSU Knight Cancer Institute 🇺🇸 🇧🇷 in #PDX #PNW 🏔️ 🌲 🌊 ASCO FCOI: https://t.co/8W15jPkVs7
Flavio G Rocha, MD, FACS, FSSO
 @FlavioRochaMD
11 เม.ย.

Always bittersweet to leave @curecc #ccfac25 but feeling inspired with all the progress and future directions in #cholangiocarcinoma 💚 #onward #endcancer

FlavioRochaMD's tweet image. Always bittersweet to leave @curecc #ccfac25 but feeling inspired with all the progress and future directions in #cholangiocarcinoma 💚 #onward #endcancer
FlavioRochaMD's tweet image. Always bittersweet to leave @curecc #ccfac25 but feeling inspired with all the progress and future directions in #cholangiocarcinoma 💚 #onward #endcancer
FlavioRochaMD's tweet image. Always bittersweet to leave @curecc #ccfac25 but feeling inspired with all the progress and future directions in #cholangiocarcinoma 💚 #onward #endcancer
FlavioRochaMD's tweet image. Always bittersweet to leave @curecc #ccfac25 but feeling inspired with all the progress and future directions in #cholangiocarcinoma 💚 #onward #endcancer
0
5
34
0
2พัน
gagan_brar24's profile picture. GI Medical Oncologist with a research focus in #BTC/#CRC @cityofhope
Gagan Brar
 @gagan_brar24
3 ต.ค.

Great talk by friend, colleague and awesome surgeon @laleh_melstrom reviewing conversion to surgical resection in #cholangiocarcinoma at the CCA Summit 2025 @cityofhope @CityofHopeSurg @curecc

gagan_brar24's tweet image. Great talk by friend, colleague and awesome surgeon @laleh_melstrom reviewing conversion to surgical resection in #cholangiocarcinoma at the CCA Summit 2025 @cityofhope @CityofHopeSurg @curecc
1
10
27
1
3พัน
curecc's profile picture. Our mission is to find a cure and improve the quality of life for cholangiocarcinoma patients. #CCAhope
Cholangiocarcinoma Foundation
@curecc
5 ก.ค.

A CCA survivor thriver, his wife & his oncologist, Dr. Katie Kelley, just climbed to the top of Salesforce Tower 💪 She’s a CCF Innovation Grant recipient & Mark R. Clements Awardee—and a true partner in the climb toward a cure. #Cholangiocarcinoma #LivingBeyondDiagnosis…

curecc's tweet image. A CCA survivor thriver, his wife & his oncologist, Dr. Katie Kelley, just climbed to the top of Salesforce Tower 💪 She’s a CCF Innovation Grant recipient & Mark R. Clements Awardee—and a true partner in the climb toward a cure. #Cholangiocarcinoma #LivingBeyondDiagnosis…
0
2
19
0
542
DeCarlis_R's profile picture. 🇮🇹 HPB & Transplant Surgeon (liver/kidney/pancreas). Laparoscopy & robot. DCD & machine perfusion. Fond of my job. Tweets are my own.
Riccardo De Carlis
 @DeCarlis_R
6 ส.ค.

Right hemi-hepatectomy plus total caudate lobectomy for perihilar #cholangiocarcinoma

DeCarlis_R's tweet image. Right hemi-hepatectomy plus total caudate lobectomy for perihilar #cholangiocarcinoma
1
1
24
2
1พัน

Something went wrong.


Something went wrong.


United States Trends